Stroke is a big problem with over 800,000 strokes per year and over $34 billion spent on diagnosis and treatment.
Ischemia Care's first test, ISCDX, is designed to "Take the Mystery out of Cryptogenic Stroke".
Ischemia Care's deep diagnostic pipeline covers the entire stroke care continuum when critical information is needed, from "point of care" through hospitalization.
Ischemia Care proprietary RNA expression testing is built upon significant peer reviewed clinical data, as well as other abstracts, presentations, white papers, etc.
Atrial Fibrillation & Ischemic Stroke
Cryptogenic Stroke
Cryptogenic stroke accounts for 30% to 40% of ischemic stroke. It is essential to determine the possible cause because this will improve secondary stroke prevention strategies. Ischemic Stroke Lab is "Taking the mystery out of cryptogenic stroke."
Hospital Cost Savings
Learn about our ISC cost effectiveness program to improve care and reduce hospital costs for your hospital.
Technology Overview
The Ischemia Care platform of testing and services is built on sound science.
BASE Clinical Trial
The Biomarkers of Acute Stroke Etiology clinical trial is one of the most successful stroke biomarker clinical trial ever conducted.